Search Results

PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.

Ascensia Diabetes Care and Senseonics Holdings, Inc. have launched a new U.S. advertising and marketing campaign for Eversense® E3 CGM System.

Senseonics Holdings, Inc. in partnership with our global commercial partner, Ascensia Diabetes Care, and St. Louis-based Mercy, a leading health care system and accountable care organization, announced a first-of-its-kind relationship in a diabetes population management program.

Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces a landmark global collaboration with SNAQ, an award-winning app-based solution that offers key insights on food and nutrition for people with diabetes.

Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has significantly expanded Eversense PASS, a Payment Assistance and Simple Savings program designed to enhance affordability and access to the Eversense E3 CGM System.

Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ® Blood Glucose Monitoring (BGM) system portfolio and exclusive distributor of Eversense ® Continuous Glucose Monitoring (CGM) Systems, marks the one-year anniversary of launching Eversense ® E3 in the U.S. with a commercial update and outlook on future innovation.

Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® blood glucose monitoring system portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring Systems, announces that it has relaunched its successful ‘This is Diabetes’ art and photo competition in support of World Diabetes Day 2022.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced the appointment of Jean-Claude “JC” Kyrillos as Executive Vice President and Chief Operating Officer, effective June 21, 2024.